Warfarin and cancer

New York, June 30, 2000 (Praxis Press) - The incidence of cancer increases after the diagnosis of venous thromboembolism, which is usually treated with vitamin K antagonists such as warfarin. Few randomized trials have examined the relation between the development of metastases and the clotting mechanism. During a prospective, randomized study that lasted eight years, Schulman and Lindmarker have compared the effects on the incidence of cancer of a six-week and a six-month warfarin treatment giv

June 30, 2000

New York, June 30, 2000 (Praxis Press) - The incidence of cancer increases after the diagnosis of venous thromboembolism, which is usually treated with vitamin K antagonists such as warfarin. Few randomized trials have examined the relation between the development of metastases and the clotting mechanism. During a prospective, randomized study that lasted eight years, Schulman and Lindmarker have compared the effects on the incidence of cancer of a six-week and a six-month warfarin treatment given to patients after a first episode of venous thromboembolism (see paper). The study shows that while the incidence of cancers is higher during the first two years -- overall ratio of 3.4 -- it is lower in the patients who received the six-month warfarin treatment, 10.3 percent vs. 15.8 percent. The study strongly suggests that warfarin has an antineoplastic effect, although its mechanism is still unknown. While such data are too scarce to justify prescribing anticoagulants to patients at high risk of cancer, they warrant more controlled clinical trials to examine the relation of warfarin with cancer.

Popular Now

  1. Antarctica Is Turning Green
  2. How to Tell a Person’s “Brain Age”
  3. Male Fish Borrows Egg to Clone Itself
  4. Life Science Funding Cuts Leaked
    The Nutshell Life Science Funding Cuts Leaked

    According to a document posted online less than a day before the release of the official 2018 budget proposal, the National Institutes of Health could face even deeper cuts than previously suggested by the Trump administration.

AAAS